Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (11-20 of 514) with videos related to

Pageof 52
Sort By:
Investigational New Drugs|November 18, 2000
The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potentialP M Hoff
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Novel agents and targets for the therapy of advanced colon cancerPaulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Is there a role for routine p53 testing in colorectal cancer?Paulo M Hoff
The Netherlands Journal of Medicine|January 1, 1975
A patient with murine typhusA M Hoff
Nature Clinical Practice. Oncology|November 3, 2005
Oxaliplatin-related neurotoxicity: is chelation the solution?Paulo M Hoff
Seminars in Oncology|December 6, 2006
Bevacizumab in older patients and patients with poorer performance statusPaulo M Hoff
Laryngo- Rhino- Otologie|November 23, 2000
[Neuroendocrine tumors of the larynx (NETL)]M Hoff, B Kramp
Nederlands Tijdschrift Voor Tandheelkunde|June 2, 2001
[Syndromes 20. Tuberous sclerosis complex]M Hoff, A Vissink
Investigative Ophthalmology|May 1, 1970
Retinal function in an isolated, perfused mammalian eyeP Gouras, M Hoff
Oncology (Williston Park, N.Y.)|August 12, 1999
Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinomaP M Hoff, R Pazdur
Pageof 52

Showing results (11-20 of 514) with videos related to

Sort By:
Pageof 52
Investigational New Drugs|November 18, 2000
The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potentialP M Hoff
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Novel agents and targets for the therapy of advanced colon cancerPaulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Is there a role for routine p53 testing in colorectal cancer?Paulo M Hoff
The Netherlands Journal of Medicine|January 1, 1975
A patient with murine typhusA M Hoff
Nature Clinical Practice. Oncology|November 3, 2005
Oxaliplatin-related neurotoxicity: is chelation the solution?Paulo M Hoff
Seminars in Oncology|December 6, 2006
Bevacizumab in older patients and patients with poorer performance statusPaulo M Hoff
Laryngo- Rhino- Otologie|November 23, 2000
[Neuroendocrine tumors of the larynx (NETL)]M Hoff, B Kramp
Nederlands Tijdschrift Voor Tandheelkunde|June 2, 2001
[Syndromes 20. Tuberous sclerosis complex]M Hoff, A Vissink
Investigative Ophthalmology|May 1, 1970
Retinal function in an isolated, perfused mammalian eyeP Gouras, M Hoff
Oncology (Williston Park, N.Y.)|August 12, 1999
Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinomaP M Hoff, R Pazdur
Pageof 52